abstract |
The present invention relates to a composition for preventing or treating non-alcoholic fatty liver disease or metabolic syndrome comprising a flagellin fusion protein, and more particularly, flagellin, a fragment thereof or a variant thereof; And it relates to a composition for preventing or treating non-alcoholic fatty liver disease or metabolic syndrome comprising a fusion protein comprising an immunoglobulin Fc region. The composition of the present invention is very effective in treating obesity, insulin resistance, diabetes, metabolic syndrome including fatty liver and non-alcoholic fatty liver disease, and can be very usefully used for preventing or developing therapeutic agents for non-alcoholic fatty liver disease or metabolic syndrome. . |